[Analysis of 516 reports of reactions after the transfusion of labile blood products].
D001530:Belgium; D001769:Blood / Q000382:microbiology; D001771:Blood Banks / Q000706:statistics & numerical data; D016913:Blood Component Transfusion / Q000009:adverse effects* / Q000706:statistics & numerical data; D001793:Blood Preservation / Q000379:methods; D017707:Erythrocyte Transfusion / Q000009:adverse effects; D005334:Fever / Q000453:epidemiology / Q000209:etiology; D005568:Forms and Records Control; D006680:HLA Antigens / Q000276:immunology; D006461:Hemolysis; D006785:Hospitals, University / Q000706:statistics & numerical data; D006801:Humans; D006967:Hypersensitivity / Q000453:epidemiology / Q000209:etiology; D007022:Hypotension / Q000453:epidemiology / Q000209:etiology; D015994:Incidence; D007239:Infections / Q000453:epidemiology / Q000209:etiology / Q000635:transmission; D007937:Leukapheresis; D007962:Leukocytes; D017713:Platelet Transfusion / Q000009:adverse effects; D011654:Pulmonary Edema / Q000453:epidemiology / Q000209:etiology; D011786:Quality Control; D012189:Retrospective Studies; D012308:Risk Management / Q000706:statistics & numerical data*; D012699:Serology
Analyse de 516 rapports de réaction après transfusion de produits sanguins labiles.